Baron, J., "Cigarette smoking and Parkinson's disease", Neurology, vol. 36, pp. 1490-1496 (1986). |
Benwell, M. et al., "Evidence that Tobacco Smoking Increses the Density of (-)-�.sup.3 H! Nicotine Binding Sites in Human Brain", Journal of Neurochemistry, vol. 50, pp. 1243-1247 (1988). |
Clark, P. et al., "Electrophysiological actions of nicotine on substantia nigra single units", Br. J. Pharm., vol. 85, pp. 827-835 (1985). |
Decina, P. et al., "Cigarette Smoking and Neuroleptic-Induced Parkinsonism", Biol. Psychiatry, vol. 28, pp. 502-508 (1990). |
Giacobini, E., "Pharmacotherapy of Alzheimer's Disease: New Drugs and Novel Strategies", Alzheimer's Disease: Advances in Clinical and Basic Research, S61, pp. 529-538 (1993). |
Giacobini, E., "New Cholinesterase Inhibitors for Treatment of Alzheimer's Disease", Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, S80, pp. 627-631 (1991). |
Giacobini, E., "Cholinergic Receptors in Human Brain: Effects of Aging and Alzheimer's Disease", Journal of Neuroscience Research, vol. 27, pp. 548-560 (1990). |
Giacobini, E., "The Second Generation of Cholinesterasse Inhibitors: Pharmacological Aspects", Pharmacological Basis of Cholinergic Therapy of Alz. Dis., Eds., Becker, R. et al. Boxton:Birkhauser (1991). |
Giacobini, E. et al., "Toward a Third Generation of Cholinesterase Inhibitors", Pharmacological Basis of Cholinergic Therapy of Alz. Dis., Eds., Becker, R. et al., Boxton:Birkhauser (1991). |
Hall, G. et al., "Effects of Nicotine on the Release of .sup.3 H-Noradrenaline from the Hypothalamus", Biochemical Pharmacology, vol. 21, pp. 1829-1838 (1972). |
Harsing, L. et al., "Dopamine Efflux from Striatum After Chronic Nicotine: Evidence for Autoreceptor Desensitization", Journal of Neurochemistry, vol. 59, pp. 48-54 (1993). |
Hery, F. et al., "Control of the Release of Newly Synthetized .sup.3 H-5-Hydroxytryptamine by Nicotinic and Muscarinic Receptors in Rat hypothalamic Slices", Arch. Int. Pharmacodyn. Ther., vol. 296, pp. 91-97 (1977). |
Janson, A. et al., "Protective effects of chronic nicotine treatment on lesioned nigrostriatal dop neurons in the male rat", Progress in Brain Research, vol. 79, pp. 257-265 (1989). |
Jarvik, M. "Beneficial effects of nicotine", British Journal of Addition, vol. 86, pp. 571-575 (1991). |
Jones, A. et al., "Alzheimer's Disease: Clinical and Pathological Characteristics", Intern. J. Neuroscience, vol. 50, pp. 147-168 (1990). |
Marks, M. et al., "Effects on Chronic Nicotine Infusion on Tolerance Development and Nicotinic Receptors", The Journal of Pharmacology and Experimental Therapeutics, vol. 226, pp. 817-825 (1983). |
Hughes, "Proceedings from Intl. Symp. Nic.", S40 (1994). |
Newhouse, P. et al., "Intravenous nicotine in Alzheimer's disease: a pilot study", Psychopharmacology, vol. 95, pp. 171-175 (1988). |
Nordberg, A. et al., "The role of nicotinic receptors in the pathophysiology of Alzheimer's disease", Progress in Brain Research, vol. 79, pp. 353-362 (1989). |
Onaivi, E. et al., "Chronic Nicotine Reverses Age-Associated Increases in Tail-Flick Latency and Anxiety in Rats", Life Sciences, vol. 54, pp. 193-202 (1994). |
Perry E., "The Cholinergic Hypothesis-Ten Years On", British Medical Bulletin, vol. 42, pp. 63-69 (1986). |
Pomponi, M. et al., "Present state and future development of the therapy of Alzheimer disease", Aging, vol. 2(2), pp. 125-153 (1990). |
Rapier, C. et al., "Stereoselective Nicotine-Induced Release of Dopamine from Striatal Synaptosomes: Concentration Dependence and Repetitive Stimulation", Journal of Neurochemistry, vol. 50, pp. 1123-1130 (1988). |
Rinne, J. et al., "A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease", Brain Research, vol. 547, pp. 167-170 (1991). |
Rowell, P., "Current Concepts on the Effects of Nicotine on Neurotransmitter Release in the Central Nervous System", Adv. Behav. Biol., vol. 31, pp. 191-208 (1987). |
Rowell, P. et al., "Nicotinic Stimulation of �.sup.3 H! Acetylcholine Release form Mouse Cerebral Cortical Synaptosomes", Journal of Neurochemistry, vol. 43, pp. 1593-1598 (1984). |
Sahakian, B. et al., "The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type", British Journal of Psychiatry, vol. 154, pp. 797-800 (1989). |
Sanberg, P. et al., "Nicotine Potentiation of Haloperidol-Induced Catalepsy: Striatal Mechanisms", Pharmacology Biochemistry and Behavior, vol. 46, pp. 303-307 (1993). |
Sandor, N. et al., "Effect of nicotine on dopaminergic-cholinergic interaction in the striatum", Brain Research, vol. 567, pp. 313-316 (1991). |
Sherwood, Human Psychopharm., vol. 8, pp. 155-184 (1993). |
Sjak-Shie, N. et al., "Effects of chronic nicotine and pilocarpine administration on neocortical neuronal density and �.sup.3 H! GABA uptake in nucleus basalis lesioned rats", Brain Research, vol. 624, pp. 295-298 (1993). |
Smith, C. et al., "Nicotine, Parkinson's and Alzheimer's Disease", Rev. in Neuroscience, vol. 3, pp. 25-43 (1992). |
Toth, E. et al., "Effect of Nicotine on Extracellular Levels of Neurotransmitters Assessed by Microdialysis in Various Brain Regions: Role of Glutamic Acid", Neurochemical Research, vol. 17(3), pp. 265-271 (1992). |
van Duijan, C. et al., "Relation between nicotine intake and Alzheimer's disease", BMJ, vol. 302, pp. 1491-1494 (1991). |
Vizi, E., "Acetylcholine release from guinea-pig ileum by parasympathetic ganglion stimulants and gastrin-like polypeptides", British Journal Pharmacology, vol. 47, pp. 765-777 (1973). |
Physicians' Desk Reference, 48 Edition, pp. 899-903 (1994), "Sinemet". |
Physicians' Desk Reference, 48 Edition, pp. 2067-2069 (1994), "Parlodel". |
Physicians' Desk Reference, 48 Edition, pp. 2309-2311 (1994), "Eldepryl". |
Hodges, H. et al., "Nicotine as a Tool to Characterize the Role of the Forebrain Cholinergic Projection System in Cognition", Biology of Nicotine, pp. 157-182(1991). |
Pomerleau, et al., "The Effects of Cigarette Smoking on Pain and Anxiety", Addictive Behavi 9, pp. 265-271 (1984). |
Wagner, et al., "Does Smoking Reduce the Risk of Neuroleptic Parkinsonoids?", Pharmacopsychiatry, vol. 21, pp. 302-303 (1988). |
Baron, J. "Proceedings from Intl. Symp. Nic.", S42 (1994). |
Janson, A. et al., "Proceedings from Intl. Symp. Nic.", S43 (1994). |
Levin, E. et al., "Proceedings from Intl. Symp. Nic.", S44 (1994). |
Joseph M. et al., "Proceedings from Intl. Symp. Nic.", S45 (1994). |
Newhouse, P. et al., "Proceedings from Intl. Symp. Nic.", S46 (1994). |